How many institutions held PHVS - Pharvaris N.V. - Ordinary shares, par value Euro 0.12 per share in Q4 2023?

36 institutional investors reported PHVS - Pharvaris N.V. - Ordinary shares, par value Euro 0.12 per share for Q4 2023. Use the holders table for investor-level position and value details.

Pharvaris N.V. - Ordinary shares, par value Euro 0.12 per share (PHVS)

Q: What does CUSIP N69605108 represent in this 13F holders report?

CUSIP N69605108 is the security identifier for PHVS - Pharvaris N.V. - Ordinary shares, par value Euro 0.12 per share used to aggregate holder disclosures.

CUSIP: N69605108

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Ordinary shares, par value Euro 0.12 per share
Total 13F shares: 40,745,703
Total 13F value: $1,142,917,292
Share change: +11,678,601
SEC-reported price per share: $28.05
Number of holders: 36
Value change: +$327,949,428
Number of buys: 30
Number of sells: 7
Shares outstanding: 70,522,724

Security key

N69605108

Report period

Q4 2023

Institutions

Top holders

PHVS full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Pharvaris N.V. SEC filings Pharvaris N.V. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP N69605108

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q3 2025

Ownership snapshot

Top reported holders of PHVS - Pharvaris N.V. - Ordinary shares, par value Euro 0.12 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Bain Capital Life Science...

Disclosed value leader

Bain Capital Life Science...

Comparable rows

0/15

Latest evidence

30 Sep 2023

13F Highest disclosed value: $99,856,146 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bain Capital Life Sciences Investors, LLC has the largest disclosed position value at $99.86M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bain Capital Life Sciences Investors, LLC's linked filing trail.

Disclosed position value Top 5

Bain Capital Life Sciences Invest... $99.86M

GENERAL ATLANTIC, L.P. $91.96M

venBio Partners LLC $89M

Foresite Capital Management IV, LLC $78.13M

VIKING GLOBAL INVESTORS LP $67.45M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bain Capital Life Sciences Investors, LLC	13F Company 13F	— denominator unverified	$99,856,146 4,784,674 shares	—	30 Sep 2023
GENERAL ATLANTIC, L.P.	13F Company 13F	— denominator unverified	$91,958,479 4,406,252 shares	—	30 Sep 2023
venBio Partners LLC	13F Company 13F	— denominator unverified	$89,003,705 4,264,672 shares	—	30 Sep 2023
Foresite Capital Management IV, LLC	13F Company 13F	— denominator unverified	$78,125,802 3,743,450 shares	—	30 Sep 2023
VIKING GLOBAL INVESTORS LP	13F Company 13F	— denominator unverified	$67,450,233 3,231,923 shares	—	30 Sep 2023
Venrock Adviser, LLC	13F Company 13F	— denominator unverified	$32,630,516 1,563,513 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

40,745,703

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2023 holders

Holder diff

-47

Investor	Q3 2025 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend